Dr Reddys Laboratories (RDY) Net Income (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Net Income (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.09 Bn | 7.44 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.16% |
| Mar 31, 2023 | 47.01% |
| Dec 31, 2022 | 76,973,584.21% |
| Jun 30, 2021 | 74.03% |
| Sep 30, 2020 | -203.85% |
| Jun 30, 2020 | 31.65% |
| Sep 30, 2019 | -36.45% |
| Jun 30, 2019 | -25.17% |
| Mar 31, 2019 | 126.98% |
| Dec 31, 2018 | -10.00% |
| Sep 30, 2018 | 6.06% |
| Jun 30, 2018 | 4.76% |
| Mar 31, 2018 | 43.18% |
| Dec 31, 2017 | -16.98% |
| Dec 31, 2016 | -74.42% |
| Mar 31, 2016 | 45.31% |
| Dec 31, 2015 | -26.44% |
| Sep 30, 2015 | -20.91% |
| Dec 31, 2014 | -21.43% |
| Mar 31, 2014 | -3.16% |